Dr. Cheng Liu (“Dr. Liu”), is the founder and has served as the president and chief executive officer of Eureka since May 2006. Prior to that, Dr. Liu was a principal scientist in antibody drug discovery at Chiron Corporation (now integrated into Novartis), where he championed the anti-CSF1 antibody program for the treatment of bone metastases to human clinical trials. He is the inventor of multiple issued US patents in drug discovery. In 2007, he was awarded a Special US Congressional Recognition for his contributions to improving human health.Dr. Liu received his bachelor’s degree in cell biology and genetics from Peking University ( 北京大學 ) in the PRC in July 1988 and a Ph.D. in molecular cell biology from the University of California, Berkeley in the United States in May 1996.